Literature DB >> 24928850

Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells.

Kazuya Sugiyama1, Hiroaki Kajiyama2, Kiyosumi Shibata1, Hong Yuan1, Fumitaka Kikkawa1, Takeshi Senga3.   

Abstract

The TGFβ-mediated alteration of the tumor microenvironment plays a crucial role in tumor progression. Mesothelial cells are the primary components of the tumor microenvironment for ovarian cancer cells; however, the exact role of TGFβ-stimulated mesothelial cells in ovarian cancer progression remains uncertain. In this report, we examined the effects of TGFβ-treated mesothelial cells on ovarian cancer progression. We show that TGFβ-stimulated human primary mesothelial cells (HPMC) are able to promote cancer cell attachment and proliferation and the activation of the promoter activities of MMP-2 and MMP-9, which are metalloproteinases necessary for tumor invasion. Expression of the miR200 family was downregulated in HPMCs by TGFβ stimulation, and restoration of the expression of miR200 family members in HPMCs suppressed cancer cell attachment and proliferation. Downregulation of the miR200 family by TGFβ induced fibronectin 1 production, which promoted cancer cell attachment to HPMCs. Finally, we demonstrated that the delivery of the miR200s to mesothelial cells in mice inhibited ovarian cancer cell implantation and dissemination. Our results suggest that alteration of the tumor microenvironment by the miR200 family could be a novel therapeutic strategy for ovarian cancer treatment. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24928850     DOI: 10.1158/1535-7163.MCT-14-0135

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  13 in total

Review 1.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

2.  CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.

Authors:  Hiroaki Yasui; Hiroaki Kajiyama; Satoshi Tamauchi; Shiro Suzuki; Yang Peng; Nobuhisa Yoshikawa; Mai Sugiyama; Kae Nakamura; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2019-09-21       Impact factor: 5.150

3.  Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis.

Authors:  Chi-Ruei Huang; Chung-Ta Lee; Kwang-Yu Chang; Wen-Chang Chang; Yao-Wen Liu; Jenq-Chang Lee; Ben-Kuen Chen
Journal:  Oncotarget       Date:  2015-05-10

4.  PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells.

Authors:  Nobuhisa Yoshikawa; Hiroaki Kajiyama; Kae Nakamura; Fumi Utsumi; Kaoru Niimi; Hiroko Mitsui; Ryuichiro Sekiya; Shiro Suzuki; Kiyosumi Shibata; David Callen; Fumitaka Kikkawa
Journal:  Oncol Rep       Date:  2016-03-03       Impact factor: 3.906

5.  Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells.

Authors:  Tomohiro Arita; Daisuke Ichikawa; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Shinpei Ogino; Yuji Fujita; Hidekazu Hiramoto; Junichi Hamada; Katsutoshi Shoda; Toshiyuki Kosuga; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Oncotarget       Date:  2016-08-30

6.  Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.

Authors:  Akiko Shimbo; Hiroaki Kajiyama; Satoshi Tamauchi; Nobuhisa Yoshikawa; Yoshiki Ikeda; Kimihiro Nishino; Shiro Suzuki; Kaoru Niimi; Jun Sakata; Fumitaka Kikkawa
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906

Review 7.  The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

8.  Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells.

Authors:  Kae Nakamura; Yang Peng; Fumi Utsumi; Hiromasa Tanaka; Masaaki Mizuno; Shinya Toyokuni; Masaru Hori; Fumitaka Kikkawa; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

9.  Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.

Authors:  Jun Sakata; Fumi Utsumi; Shiro Suzuki; Kaoru Niimi; Eiko Yamamoto; Kiyosumi Shibata; Takeshi Senga; Fumitaka Kikkawa; Hiroaki Kajiyama
Journal:  Oncotarget       Date:  2017-08-10

10.  Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.

Authors:  Masato Yoshihara; Hiroaki Kajiyama; Akira Yokoi; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Wenting Liu; Kae Nakamura; Yoshinori Moriyama; Hiroaki Yasui; Shiro Suzuki; Yusuke Yamamoto; Carmela Ricciardelli; Akihiro Nawa; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2020-01-24       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.